HNF4A mRNA therapeutics

N/A

Report date: 2025/03/20 15:14:56
NME

Base Information

Drug NameHNF4A mRNA therapeutics
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Lipid
Mechanisms of ActionHepatocyte nuclear factor 4 modulators
TargetsHepatocyte nuclear factor 4
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCureVac NV
China Registration ClassN/A

Develop Information

Active CompaniesMedizinische Hochschule HannoverCureVac NV
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A